Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-28 @ 9:01 AM
Study NCT ID:
NCT06402435
Status:
RECRUITING
Last Update Posted:
2025-07-02
First Post:
2024-04-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
Sponsor:
Hubei Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-27
First Submit QC Date:
None
Study First Post Date:
2024-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-27
Last Update Post Date:
2025-07-02
Last Update Post Date Type:
ACTUAL